Latest Breaking News On - B future health - Page 1 : vimarsana.com

Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion

Epsilogen Announces Successful Completion of First Ever Clinical Trial of an IgE Antibody; Phase I Data for MOv18 IgE Demonstrates Potential of IgE Therapy in Cancer

Investegate |Schroder UK PublicPT Announcements | Schroder UK PublicPT: Investment in iOnctura

Investegate announcements from Schroder UK PublicPT, Investment in iOnctura

Luxembourg: 3B Future Health launches fund to specialise on oncology start ups

LaingBuisson News 3B Future Health has launched 3B Future Health Fund II, a fund that will focus on early-stage investment opportunities in the US and Europe. It will target investments in start-ups specialising in oncology and rare disease therapeutics. The latest fund follows on from an earlier Fund I, formerly known as Helsinn Investment Fund, and is… You must be a HMI Subscriber to view this content. Nick Herbert has over 30 years’ experience in the financial markets, as both a practitioner and journalist. He started work as an investment banker in London, before joining International Financing Review (IFR) to report on debt capital markets and derivatives. He moved to Singapore in 2000 to manage IFR’s financial markets editorial team throughout Asia, before returning to London in 2009 to take up the position of Publisher for Reuters Capital Markets Publications. For the last five years he has been covering global capital markets, ESG finance and healthcare markets on a freelance basis.